Difference between revisions of "Glutamate dehydrogenase"
Jump to navigation
Jump to search
Fiorecastro (talk | contribs) |
|||
Line 27: | Line 27: | ||
== Authors & References == | == Authors & References == | ||
[[NationWide Laboratories]] | [[NationWide Laboratories]] | ||
+ | [[Category:Clinical Chemistry]] |
Revision as of 15:59, 21 April 2022
GLDH Introduction
Virtually liver specific, this enzyme is localised almost exclusively in the mitochondria of hepatocytes. It is generally considered that a severe insult is required to bring about its release and it is therefore not a sensitive general marker for hepatic disease. However, GLDH has been demonstrated to be a sensitive marker of hepatocellular necrosis in the dog irrespective of its severity.
Small Animals
Causes of increased GLDH activity
- Hepatocellular necrosis
- Secondary hepatopathies (for example, congestive heart failure and small intestinal pathology)
Complementary tests
ALT, albumin, bilirubin and bile acids.
Equine
GLDH has a relatively short half life in the horse (12-14 hours) compared to LDH, AST and GGT. Elevated levels therefore indicate active hepatocellular damage.
Causes of increased GLDH activity
- Hepatocellular necrosis
- Enteropathy – common and levels can be quite high
Complementary tests
AST, GGT (hepatocellular damage) and bile acids (hepatic function).